Literature DB >> 8528374

Temporal quantification of Alzheimer's disease severity: 'time index' model.

J W Ashford1, M Shan, S Butler, A Rajasekar, F A Schmitt.   

Abstract

A fundamental issue in the clinical and neuropathological assessment of Alzheimer's disease patients is quantification of dementia severity progression. Several methods have been advanced for the purpose of staging dementia with various sensitivities at different phases of the disease, but no mathematical function has been developed to link these measures to a physical continuum. Using a dynamic method for quantifying illness severity, change in severity over time was referenced to a cumulative temporal index, a physical dimension. Data from 33 patients with probable Alzheimer's disease with at least 2 successive assessments on three 50-point scales measuring cognitive, behavioral, and daily living skills were used to determine rate of change. 'Fuzzylogic' smoothing of the data, integration over time, and least-squares regression were used to derive a cubic polynomial function to calculate a severity measure in which 'days of illness' was estimated from the severity score. This method can be used to improve the comparability of performance across various mental status tests, and to link measures of very early phases of preclinical dementia and late profound dementia phases. This method also provides a description of an 'average' time course for any population from which the index is derived.

Entities:  

Mesh:

Year:  1995        PMID: 8528374     DOI: 10.1159/000106958

Source DB:  PubMed          Journal:  Dementia        ISSN: 1013-7424


  12 in total

1.  Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognition.

Authors:  Kathryn P Riley; Gregory A Jicha; Daron Davis; Erin L Abner; Gregory E Cooper; Nancy Stiles; Charles D Smith; Richard J Kryscio; Peter T Nelson; Linda J Van Eldik; Frederick A Schmitt
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 2.  Dependence as a unifying construct in defining Alzheimer's disease severity.

Authors:  Trent McLaughlin; Howard Feldman; Howard Fillit; Mary Sano; Frederick Schmitt; Paul Aisen; Christopher Leibman; Lisa Mucha; J Michael Ryan; Sean D Sullivan; D Eldon Spackman; Peter J Neumann; Joshua Cohen; Yaakov Stern
Journal:  Alzheimers Dement       Date:  2010-11       Impact factor: 21.566

3.  MR spectroscopy for assessment of memantine treatment in mild to moderate Alzheimer dementia.

Authors:  J W Ashford; M Adamson; T Beale; D La; B Hernandez; A Noda; A Rosen; R O'Hara; J K Fairchild; D Spielman; J A Yesavage
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 4.  Modeling the time-course of Alzheimer dementia.

Authors:  J W Ashford; F A Schmitt
Journal:  Curr Psychiatry Rep       Date:  2001-02       Impact factor: 5.285

5.  Independent contributions of neural and "higher-order" deficits to symptoms in Alzheimer's disease: a latent variable modeling approach.

Authors:  Rochelle E Tractenberg; Paul S Aisen; Myron F Weiner; Jeffrey L Cummings; Gregory R Hancock
Journal:  Alzheimers Dement       Date:  2006-10       Impact factor: 21.566

6.  A computational neurodegenerative disease progression score: method and results with the Alzheimer's disease Neuroimaging Initiative cohort.

Authors:  Bruno M Jedynak; Andrew Lang; Bo Liu; Elyse Katz; Yanwei Zhang; Bradley T Wyman; David Raunig; C Pierre Jedynak; Brian Caffo; Jerry L Prince
Journal:  Neuroimage       Date:  2012-08-03       Impact factor: 6.556

Review 7.  APOE genotype effects on Alzheimer's disease onset and epidemiology.

Authors:  J Wesson Ashford
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

8.  Additive scales in degenerative disease--calculation of effect sizes and clinical judgment.

Authors:  Matthias W Riepe; David Wilkinson; Hans Förstl; Andreas Brieden
Journal:  BMC Med Res Methodol       Date:  2011-12-16       Impact factor: 4.615

9.  A Computerized Continuous-Recognition Task for Measurement of Episodic Memory.

Authors:  J Wesson Ashford; Franck Tarpin-Bernard; Curtis B Ashford; Miriam T Ashford
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

10.  The MemTrax Test Compared to the Montreal Cognitive Assessment Estimation of Mild Cognitive Impairment.

Authors:  Marjanne D van der Hoek; Arie Nieuwenhuizen; Jaap Keijer; J Wesson Ashford
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.